How to Optimize the Care Cascade of Hepatitis C Virus Infection

참고문헌 (10)

1. Polaris Observatory HCV Collaborators, "Global prevalence and genotype distribution of hepatitis C virus infection in 2015 : a modelling study", Lancet Gastroenterol Hepatol, 2, pp.161~176 (2017)
2. Sarin SK, "Liver diseases in the Asia-Pacific region : a Lancet Gastroenterology & Hepatology Commission", Lancet Gastroenterol Hepatol, 5, pp.167~228 (2020)
3. Omar Alshuwaykh, "Current and future strategies for the treatment of chronic hepatitis C", Clinical and Molecular Hepatology, 27(2), pp.246~256 (2021), 대한간학회[DOI]
4. World Health Organization (WHO), "Combating hepatitis B and C to reach elimination by 2030", WHO, ~ (2016)
5. European Association for the Study of the Liver, "EASL recommendations on treatment of hepatitis C : final update of the series☆", J Hepatol, 73, pp.1170~1218 (2020)
6. AASLD-IDSA HCV Guidance Panel, "Hepatitis C guidance 2018 update : AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection", Clin Infect Dis, 67, pp.1477~1492 (2018)
7. Schillie S, "CDC recommendations for hepatitis C screening among adults : United States, 2020", MMWR Recomm Rep, 69, pp.1~17 (2020)
8. Choi Jonggi, "The Korean Hepatitis C Virus Care Cascade in a Tertiary Institution: Current Status and Changes in Testing, Link to Care, and Treatment", Gut and Liver, 16(6), pp.964~975 (2022), 거트앤리버 소화기연관학회협의회[DOI]
9. Chung-Feng Huang, "Scaling up the in-hospital hepatitis C virus care cascade in Taiwan", Clinical and Molecular Hepatology, 27(1), pp.136~143 (2021), 대한간학회[DOI]
10. Hye-Lin Kim, "A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective", Clinical and Molecular Hepatology, 28(1), pp.91~104 (2022), 대한간학회[DOI]

관련 논문AI추천